Bone microarchitecture is impaired in premenopausal women with active celiac disease, a new study from Argentina shows. “This report helps us to understand how bone is affected in celiac disease: increasing bone resorption and thinning trabeculae, even losing some number of them,” Dr. MarÃa Belén Zanchetta from Instituto de Diagnóstico e Investigaciones Metabólicas in Buenos…
The ACR/CHEST ILD Guidelines in Practice, a video
In collaboration with the American College of Chest Physicians, the ACR released two new comprehensive guidelines aimed at improving the screening, monitoring, and treatment of patients with interstitial lung disease (ILD) secondary to systemic autoimmune rheumatic diseases (SARDs). Recently, Sindhu R. Johnson, MD, PhD, professor of medicine at the University of Toronto, Canada, director of the Toronto Scleroderma Program and principal investigator for the guideline, and Elana J. Bernstein, MD, MSc, Florence Irving associate professor of medicine in the Division of Rheumatology at Columbia University, New York City, and co-first author, presented a webinar to talk about how the guidelines were developed and present some of the recommendations and their rationale: Watch the recording now!
Progress Made in Search for a Fibromyalgia Biomarker
Fibromyalgia syndrome (FMS), rheumatoid arthritis (RA) and spondyloarthritis (SpA) all exhibit multifaceted manifestations, and many patients exhibit overlapping comorbidities. However, patients with FMS are distinct from others in that they experience widespread pain, fatigue and mood changes, including anxiety and depression. Although its hallmark symptom of pain causes rheumatologists to consider FMS a pain disorder,…

RheumPAC: How the ACR’s Non-Partisan Political Action Committee Works
The classic American social studies lesson is How a Bill Becomes a Law, but a more pertinent lesson for U.S. rheumatologists today may be How a Dollar Bill Becomes a PAC. This article is a nuts-and-bolts primer on how exactly RheumPAC works. The purpose is to inform readers about how and why to participate. Money…

Rheumatology Research Foundation Hits 30-Year Milestone
At the 2014 ACR/ARHP Annual Meeting in Boston, the Rheumatology Research Foundation staff sat down with a few ACR and ARHP members to get their take on what the Foundation’s 30th anniversary means to them. We spoke with current and former leaders of the Foundation and the ACR, as well as numerous Foundation award recipients,…
Complement Polymorphism Plays Role in RA Pathology
Study proposes increased active C5a recruits neutrophils to arthritic joints to maintain inflammation
Ethics Forum: Terminating Hospital Consulting Services
Ethical considerations for rheumatologists in terminating consultative services to a community hospital
2014 ACR/ARHP Annual Meeting: Macrophage Activation Syndrome
The pathogenesis of and new classification criteria for MAS
2014 ACR/ARHP Annual Meeting: Methotrexate Use in Patients with RA
Review of clinical research on methotrexate therapy, effect on patients’ functionality, tolerability, adverse events
2014 ACR/ARHP Annual Meeting: Super Proteins Eyed in Therapies for Rheumatic Diseases
Immunoglobulin superfamily of proteins, CTLA-4 and PD-1, may generate treatments for RA, SLE
2014 ACR/ARHP Annual Meeting: Rheumatologic Research Uncovers Clues to Therapies
Studies explore role of STING pathway in bone remodeling, denosumab to reduce fracture risk, autotaxin’s role in fibrosis, SSc
- « Previous Page
- 1
- …
- 162
- 163
- 164
- 165
- 166
- …
- 247
- Next Page »